• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖基化人丁酰胆碱酯酶模型

A model of glycosylated human butyrylcholinesterase.

作者信息

Fang Lei, Zheng Fang, Zhan Chang-Guo

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, KY 40536, USA.

出版信息

Mol Biosyst. 2014 Feb;10(2):348-54. doi: 10.1039/c3mb70313d.

DOI:10.1039/c3mb70313d
PMID:24327294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3947857/
Abstract

Human butyrylcholinesterase (BChE) and its mutants have shown great potential in treating cocaine overdose and addiction. In order to effectively suppress cocaine reward in the brain for a long period of time after an exogenous cocaine hydrolase administration, the therapeutic enzyme should have not only a high catalytic efficiency against cocaine, but also a sufficiently long circulation time. It has been known that PEGylation (covalent attachment of polyethylene glycol) modification of a therapeutic protein can prolong the biological half-life of the protein without affecting its biological function. However, the asparagine-linked glycans on the surface of glycosylated BChE may interfere with the PEGylation modification. In this study, we built a three-dimensional (3D) model of glycosylated human BChE to investigate the influence of glycans on the PEGylation modification. Glycans did not change the overall stability of the BChE structure, but could increase the flexibility of some local structures. For further evaluating the accessibility of the PEGylation reaction sites, particularly lysine residues, on the protein surface, we calculated the Solvent Accessible Surface Areas (SASAs) of these residues. The results indicate that some lysine residues show a significant decrease in SASA due to the direct or indirect influence of their surrounding glycans. The results also indicate that PEGylation reaction agents with smaller functional groups could have a better chance to react with lysine residues. This investigation provides a structural basis for rational engineering of human BChE and its mutants as therapeutic candidates.

摘要

人丁酰胆碱酯酶(BChE)及其突变体在治疗可卡因过量和成瘾方面显示出巨大潜力。为了在外源性可卡因水解酶给药后长时间有效抑制大脑中的可卡因奖赏效应,治疗性酶不仅应具有对可卡因的高催化效率,还应具有足够长的循环时间。已知对治疗性蛋白质进行聚乙二醇化(共价连接聚乙二醇)修饰可以延长蛋白质的生物半衰期而不影响其生物学功能。然而,糖基化BChE表面的天冬酰胺连接聚糖可能会干扰聚乙二醇化修饰。在本研究中,我们构建了糖基化人BChE的三维(3D)模型,以研究聚糖对聚乙二醇化修饰的影响。聚糖并未改变BChE结构的整体稳定性,但可增加一些局部结构的灵活性。为了进一步评估蛋白质表面聚乙二醇化反应位点(特别是赖氨酸残基)的可及性,我们计算了这些残基的溶剂可及表面积(SASA)。结果表明,一些赖氨酸残基由于其周围聚糖的直接或间接影响,其SASA显著降低。结果还表明,具有较小官能团的聚乙二醇化反应剂与赖氨酸残基反应的机会可能更好。本研究为合理设计人BChE及其突变体作为治疗候选物提供了结构基础。

相似文献

1
A model of glycosylated human butyrylcholinesterase.糖基化人丁酰胆碱酯酶模型
Mol Biosyst. 2014 Feb;10(2):348-54. doi: 10.1039/c3mb70313d.
2
Amino-acid mutations to extend the biological half-life of a therapeutically valuable mutant of human butyrylcholinesterase.氨基酸突变延长人丁酰胆碱酯酶治疗价值突变体的生物半衰期。
Chem Biol Interact. 2014 May 5;214:18-25. doi: 10.1016/j.cbi.2014.02.007. Epub 2014 Feb 25.
3
Design of high-activity mutants of human butyrylcholinesterase against (-)-cocaine: structural and energetic factors affecting the catalytic efficiency.设计针对(-)-可卡因的人丁酰胆碱酯酶高活性突变体:影响催化效率的结构和能量因素。
Biochemistry. 2010 Oct 26;49(42):9113-9. doi: 10.1021/bi1011628.
4
Catalytic activities of a cocaine hydrolase engineered from human butyrylcholinesterase against (+)- and (-)-cocaine.来源于人丁酰胆碱酯酶的可卡因水解酶对(+)-和(-)-可卡因的催化活性。
Chem Biol Interact. 2013 Mar 25;203(1):57-62. doi: 10.1016/j.cbi.2012.08.003. Epub 2012 Aug 11.
5
Substrate selectivity of high-activity mutants of human butyrylcholinesterase.人丁酰胆碱酯酶高活性突变体的底物选择性。
Org Biomol Chem. 2013 Nov 21;11(43):7477-85. doi: 10.1039/c3ob41713a.
6
Computational redesign of human butyrylcholinesterase for anticocaine medication.用于抗可卡因药物治疗的人丁酰胆碱酯酶的计算重新设计。
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16656-61. doi: 10.1073/pnas.0507332102. Epub 2005 Nov 7.
7
Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine.鉴定一种对(-)-可卡因具有高活性的人丁酰胆碱酯酶突变体。
Chem Biol Interact. 2010 Sep 6;187(1-3):148-52. doi: 10.1016/j.cbi.2010.01.004. Epub 2010 Jan 11.
8
Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.可卡因在人丁酰胆碱酯酶中水解的基本反应机制。
J Am Chem Soc. 2003 Mar 5;125(9):2462-74. doi: 10.1021/ja020850+.
9
An improved cocaine hydrolase: the A328Y mutant of human butyrylcholinesterase is 4-fold more efficient.一种改良的可卡因水解酶:人丁酰胆碱酯酶的A328Y突变体效率提高了4倍。
Mol Pharmacol. 1999 Jan;55(1):83-91. doi: 10.1124/mol.55.1.83.
10
Predicted Michaelis-Menten complexes of cocaine-butyrylcholinesterase. Engineering effective butyrylcholinesterase mutants for cocaine detoxication.
J Biol Chem. 2001 Mar 23;276(12):9330-6. doi: 10.1074/jbc.M006676200. Epub 2000 Dec 4.

引用本文的文献

1
A Comprehensive Review of Cholinesterase Modeling and Simulation.胆碱酯酶建模与模拟的综合述评
Biomolecules. 2021 Apr 15;11(4):580. doi: 10.3390/biom11040580.
2
Development of a long-acting Fc-fused cocaine hydrolase with improved yield of protein expression.长效 Fc 融合可卡因水解酶的表达产量提高的开发。
Chem Biol Interact. 2019 Jun 1;306:89-95. doi: 10.1016/j.cbi.2019.04.012. Epub 2019 Apr 12.
3
Development of Fc-Fused Cocaine Hydrolase for Cocaine Addiction Treatment: Catalytic and Pharmacokinetic Properties.开发融合 Fc 的可卡因水解酶用于可卡因成瘾治疗:催化和药代动力学特性。
AAPS J. 2018 Mar 19;20(3):53. doi: 10.1208/s12248-018-0214-9.
4
Purification, characterization, and N-glycosylation of recombinant butyrylcholinesterase from transgenic rice cell suspension cultures.转基因为水稻细胞悬浮培养物的重组丁酰胆碱酯酶的纯化、表征和 N-糖基化。
Biotechnol Bioeng. 2018 May;115(5):1301-1310. doi: 10.1002/bit.26557. Epub 2018 Feb 27.

本文引用的文献

1
Pharmacokinetic approaches to treatment of drug addiction.药物成瘾治疗的药代动力学方法。
Expert Rev Clin Pharmacol. 2008 Mar;1(2):277-90. doi: 10.1586/17512433.1.2.277.
2
Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure.昆虫细胞中表达的人丁酰胆碱酯酶:基于 huprine 的亲和纯化和晶体结构。
FEBS J. 2012 Aug;279(16):2905-16. doi: 10.1111/j.1742-4658.2012.08672.x. Epub 2012 Jul 12.
3
Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose?药代动力学方法在可卡因成瘾和过量治疗中是否可行?
Future Med Chem. 2012 Feb;4(2):125-8. doi: 10.4155/fmc.11.171.
4
Hypothesis-driven medication discovery for the treatment of psychostimulant addiction.用于治疗精神兴奋剂成瘾的基于假设的药物发现。
Curr Drug Abuse Rev. 2008 Nov;1(3):303-27. doi: 10.2174/1874473710801030303.
5
Most efficient cocaine hydrolase designed by virtual screening of transition states.通过过渡态虚拟筛选设计的最有效的可卡因水解酶。
J Am Chem Soc. 2008 Sep 10;130(36):12148-55. doi: 10.1021/ja803646t. Epub 2008 Aug 19.
6
Glycoproteomic characterization of butyrylcholinesterase from human plasma.人血浆中丁酰胆碱酯酶的糖蛋白质组学表征
Proteomics. 2008 Jan;8(2):254-63. doi: 10.1002/pmic.200700720.
7
New treatments for cocaine dependence: a focused review.可卡因成瘾的新疗法:聚焦综述。
Int J Neuropsychopharmacol. 2008 May;11(3):425-38. doi: 10.1017/S1461145707008097. Epub 2007 Oct 10.
8
Free energy perturbation (FEP) simulation on the transition states of cocaine hydrolysis catalyzed by human butyrylcholinesterase and its mutants.关于人丁酰胆碱酯酶及其突变体催化可卡因水解过渡态的自由能微扰(FEP)模拟。
J Am Chem Soc. 2007 Nov 7;129(44):13537-43. doi: 10.1021/ja073724k. Epub 2007 Oct 10.
9
GLYCAM06: a generalizable biomolecular force field. Carbohydrates.GLYCAM06:一种可推广的生物分子力场。碳水化合物。
J Comput Chem. 2008 Mar;29(4):622-55. doi: 10.1002/jcc.20820.
10
Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants.可卡因与人丁酰胆碱酯酶及其突变体结合的分子动力学模拟
J Phys Chem B. 2005 Mar 17;109(10):4776-82. doi: 10.1021/jp0447136.